PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases

PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced plans to pursue a strategic collaboration with the n-Lorem Foundation and EspeRare that we ...
Nasdaq

PacBio Joins 1000 Genomes Long Read Sequencing Project to Enhance Human Genomics Research

PacBio has announced its participation in the 1000 Genomes Long Read Sequencing Project, contributing long-read transcriptome data to enhance this significant human genomics initiative. Through ...

PacBio HiFi Adopted as First-Line Sequencing Approach to Investigate Sudden Unexplained Death in Childhood (SUDC)

Applying HiFi sequencing as a first-tier assay is designed to consolidate and simplify the laboratory workflow especially in the context of post-mortem tissue and newborn dried blood spots as ...
Zacks Investment Research on MSN

PacBio stock dips post latest launch to expand multiomics capabilities

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, announced a new community-developed method, CiFi, ...

Can PacBio’s New CiFi Method Reshape PACB’s Innovation Story and Recurring Revenue Potential?

PacBio recently announced CiFi, a community-developed method that integrates chromatin conformation capture with HiFi ...
Seeking Alpha

PacBio Celebrates Nature Methods Naming Long-Read Sequencing "Method of the Year"

MENLO PARK, Calif., Jan. 13, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today celebrated long-read sequencing being named ...
WRIC

Tecan and PacBio: High Accuracy, Automated Long-read Sequencing to Accelerate Discovery in Genomics

Amit Patel, Ecosystems Director at PacBio, added: “Long-read sequencing plays an important role in generating contiguous, high quality genomes for haplotype phasing, structural variant detection, and ...
GEN

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

PacBio reports that through its partnership with China-headquartered Berry Genomics, the Sequel II CNDx system has received Class III Medical Device Registration approval from the National Medical ...
GEN

Long Life Family Study Chooses PacBio HiFi Sequencing to Unlock Clues to Exceptional Longevity

The National Institute on Aging’s Long Life Family Study (LLFS) selected PacBio technology to generate genomic and epigenomic data from as many as 7,800 participants. The effort will rely on PacBio’s ...